Agilent Posts 35 Percent Jump in Q4 Revenue, Strong Sales of Infinity LC

The company's Life Sciences Group reported $431 million in revenues, with all platforms posting double-digit sales increases including a 21-percent rise in liquid chromatography sales led by the strong performance of the 1290 and 1260 Infinity LC lines.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.